ReviewTherapeutics and clinical risk management2016

Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations.

Fatimah Al-Ani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.